Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.

被引：0
|
作者：
Wong, JB [1 ]
机构：
[1] Tufts New England Med Ctr, Boston, MA USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1062
引用
下载
收藏
页码：425A / 425A
页数：1
相关论文
共 50 条
  • [31] A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C
    Buti, M
    Medina, M
    Casado, MA
    Wong, JB
    Fosbrook, L
    Esteban, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (05) : 687 - 694
  • [32] Effectiveness of interferon alfa-2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting
    Kumar, D
    Wallington-Beddoe, C
    George, J
    Lin, R
    Samarasinghe, D
    Liddle, C
    Farrell, GC
    MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (06) : 267 - 271
  • [33] The cost-effectiveness analysis of combination of peginterferon alfa-2a and ribavirin versus combination of peginterferon alfa-2b and ribavirin in chronic hepatitis C in Poland
    Orlewska, E
    VALUE IN HEALTH, 2004, 7 (03) : 356 - 356
  • [34] Impact of interferon alfa-2b and ribavirin on the liver fibrosis progression in patients with chronic hepatitis C.
    Poynard, T
    McHutchinson, J
    Davis, G
    Esteban-Mur, R
    Goodman, Z
    Bedossa, P
    Albrecht, J
    HEPATOLOGY, 1998, 28 (04) : 497A - 497A
  • [35] Safety, efficacy, and pharmacokinetics of interferon alfa-2b plus ribavirin in children with chronic hepatitis C.
    Kelly, DA
    Bunn, SK
    Apelian, D
    Baczkowski, A
    Gupta, S
    Laughlin, M
    Cohard, M
    HEPATOLOGY, 2001, 34 (04) : 342A - 342A
  • [36] Assessment of optimal dosing frequency of pegylated interferon alfa-2B (Pegintron) in chronic hepatitis C.
    Lurie, Y
    Dusheiko, G
    Rouzier-Panis, R
    Glue, P
    HEPATOLOGY, 2000, 32 (04) : 444A - 444A
  • [37] Comparison of pegylated interferon alfa-2a and alfa-2b in combination with ribavirin in obese patients with chronic hepatitis
    Moore, CH
    Angtuaco, TL
    Lindsey, JL
    Nelson, SD
    Malik, AH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S109 - S109
  • [38] Cost Effectiveness of Peginterferon Alfa-2b Combined with Ribavirin for the Treatment of Chronic Hepatitis C in Brazil
    Machado Fonseca, Marcelo Cunio
    Branco de Araujo, Gabriela Tannus
    Araujo, Denizar Vianna
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (03): : 191 - 199
  • [39] A Chronic Subdural Hematoma in a Patient Receiving Combination Therapy with Pegylated Interferon Alfa-2b and Ribavirin for Chronic Hepatitis C
    Goto, Takashi
    Ohshima, Shigetoshi
    Miura, Kouichi
    Shibuya, Tomomi
    Sato, Wataru
    Dohmen, Takahiro
    Kamada, Kentaro
    Kanata, Ryo
    Sakai, Toshitaka
    Chiba, Mitsuru
    Sugimoto, Yuko
    Minami, Shinichiro
    Ohnishi, Hirohide
    INTERNAL MEDICINE, 2013, 52 (18) : 2057 - 2060
  • [40] The influence of cigarette smoking on response to treatment with pegylated interferon alfa-2b and ribavirin in patients with chronic hepatitis C
    Pauly, Mary P.
    Sheinbaum, Alan J.
    Szpakowski, Jean-Luc I.
    Ready, Joanna B.
    Brown, Robert S.
    Freilich, Bradley
    Afdhal, Nezam
    Kwo, Paul
    Santoro, John
    Becker, Scott
    Jacobson, Ira
    Griffel, Louis
    Brass, Clifford
    GASTROENTEROLOGY, 2006, 130 (04) : A286 - A286
12345